NGEN
$3.92-0.05 (-1.26%)
Market ClosedAs of Mar 20, 8:00 PM UTC
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.92
Potential Upside
5%
Whystock Fair Value$4.12
Price
UndervaluedFair ValueOvervalued
Fundamentals
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product ca...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$310.51M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.98
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
643.47%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.79
